Comparative effects of virulent and avirulent poxviruses on cell cycle progression

Experimental and Molecular Pathology

Volumn 66, Issue 1, 1999, Pages 31-38

  Wali, Anil ^a   Strayer, David S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN B; DNA; PROTAMINE KINASE; PROTEIN KINASE; PROTEIN P53;

ANIMAL CELL; ARTICLE; AUTORADIOGRAPHY; CELL CYCLE; ENZYME ACTIVITY; IMMUNOBLOTTING; LEPORIPOXVIRUS; NONHUMAN; ONCOVIRINAE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; RABBIT; VIRUS VIRULENCE;

ANIMALIA; DNA VIRUSES; LEPORIPOXVIRUS; ONCOVIRINAE; ORYCTOLAGUS CUNICULUS; PAPOVAVIRIDAE; POXVIRIDAE; RABBIT FIBROMA VIRUS;

EID: 0033002572     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1006/exmp.1999.2249     Document Type: Article

References (37)

1. Upton C., Macen J. L., Maranchuk R. A., DeLange A. M., McFadden G. Tumorigenic poxviruses: Fine analysis of the recombination junctions in malignant rabbit fibroma virus, a recombinant between Shope fibroma virus and myxoma virus. Virology. 183:1988;773-777.
2. Strayer D. S. Determinants of virus-related suppression of immune responses as observed during infection with an oncogenic poxvirus. Prog. Med. Virol. 39:1992;228-255.
3. Strayer D. S., Laybourn K. A., Heard H. K. Determinants of the ability of malignant fibroma virus to induce tumor dissemination in vivo. Microb. Pathogen. 9:1990;173-189.
4. Strayer D. S., Skaletsky E., Cabirac G., Sharp P. A., Corbeil L. B., Sell S., Leibowitz J. L. Malignant rabbit fibroma virus causes secondary immunosuppression in rabbits. J. Immunol. 130:1983;399-404.
5. Strayer D. S. Effect of virus infection on levels of transcripts for cellular genes. Virus Res. 30:1993;259-269.
6. Wali A., Strayer D. S. Regulation of p53 gene expression by a poxviral transcription factor. Virology. 224:1996;63-72.
7. Hartwell L. H., Weinert T. A. Checkpoints: Controls that ensure the order of cell cycle events. Science. 246:1989;629-634.
8. Hunter T. Braking the cycle. Cell. 75:1993;839-841.
9. Norbury C., Nurse P. Animal cell cycles and their control. Annu. Rev. Biochem. 61:1992;441-470.
10. Pines J. Cyclins and cyclin-dependent kinases: Take your partners. Trends Biochem. Sci. 18:1993;195-197.
11. Sherr C. J. Mammalian G1 cyclins. Cell. 73:1993;1059-1065.
12. Sherr C. J. Cancer cell cycles. Science. 274:1996;1672-1677.
13. Resnitzky D., Gossen M., Bujard H., Reed S. I. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14:1994;1669-1679.
14. Minshull J., Golsteyn R., Hill C. S., Hunt T. The A- and B-type cyclin associated cdc2 kinases inXenopus. EMBO J. 9:1990;2865-2875.
15. Elledge S. J. Cell cycle checkpoints: Preventing an identity crisis. Science. 274:1996;1664-1672.
16. DeGregori J., Kowalik T., Nevins J. R. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol. 15:1995;4215-4224.
17. Telford W. G., King L. R., Fraker P. J. Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry. 13:1992;137-143.
18. Agarwal M. L., Agarwal A., Taylor W. R., Stark G. R. p53 controls both the G2/M and the G1 cell cycle check-points and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA. 92:1995;8493-8497.
19. Toyoshima H., Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell. 78:1994;67-74.
20. Pagano M., Pepperkok P., Verde F., Ansorge W., Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J. 11:1992;961-971.
21. Riabowol K., Draetta G., Brizuela L., Vandre D., Beach D. The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells. Cell. 57:1989;393-401.
22. Welch P. J., Wang J. Y. J. Coordinated synthesis and degradation of cdc2 in the mammalian cell cycle. Proc. Natl. Acad. Sci. USA. 89:1992;3093-3097.
23. Jault F. M., Jault J., Ruchti F., Fortunato E. A., Clark C., Corbeil J., Richman D. D., Spector D. H. Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J. Virol. 69:1995;6697-6704.
24. Xiong Y., Kuppuswamy D., Li Y., Livanos E. M., Hixon M., White A., Beach D., Tlsty T. D. Alteration of cell cycle kinase complexes in human papillomavirus E6- and E7- expressing fibroblasts precedes neoplastic transformation. J. Virol. 70:1996;999-1008.
25. Strayer D. S., Horowitz M., Leibowitz J. L. Immuno-suppression in viral oncogenesis. III. Effects of virus infection on interleukin-1 and interleukin-2 generation and responsiveness. J. Immunol. 137:1986;3632-3638.
26. Wang J., Chenivesse X., Henglein B., Brechot C. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature. 343:1990;555-557.
27. Guadagno T. M., Ohtsubo M., Roberts J. M., Assioan R. K. A link between cyclin A expression and adhesion dependent cell cycle progression. Science. 262:1993;1572-1575.
28. Cardoso M. C., Leonhardt H., Nadal-Girard B. Reversal of terminal differentiation and control of DNA replication: Cyclin A and cdk2 specifically localize at subnuclear sites of DNA replication. Cell. 74:1993;979-1992.
29. Enoch T., Nurse P. Coupling M phase and S phase: Controls maintaining the dependence of mitosis on chromosome replication. Cell. 65:1991;921-923.
30. Walker D. H., Maller J. L. Role for cyclin A in the dependence of mitosis on completion of DNA replication. Nature. 354:1991;314-317.
31. Milano J., Strayer D. S. Effects of overexpression of Ran/TC4 on mammalian cellsin vitro. Exp. Cell Res. 239:1998;31-39.
32. He, J. Choe, S. Walker, R. Dimarzio, P. Morgan, D. O. Landau, N. R. Human immunodeficiency virus type 1 and viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity, J. Virol. 69, 6705, 6711.
33. cdc2. Science. 263:1994;1143-1145.
34. Furnari B., Rhind N., Russell P. Cdc25 mitotic inducer targeted by Chk1 DNA damage checkpoint kinase. Science. 277:1997;1495-1497.
35. Coleman T. R., Dunphy W. G. Cdc2 regulatory factors. Curr. Opin. Cell. Biol. 6:1994;877-882.
36. Desai D., Wessling H. C., Fisher R. P., Morgan D. O. Effects of phosphorylation by CAK on cyclin binding by CDC2 and CDK2. Mol. Cell. Biol. 15:1995;345-350.
37. Fisher D. L., Nurse P. A single fission yeast mitotic cyclin B-p34cdc2 promotes both S-phase and mitosis in the absence of G1 cyclins. EMBO J. 15:1995;850-860.